Top compounds associated with response to CNFN


Feature Type Standardized
Nominal ANOVA
mRNA Sorafenib CCLE pan-cancer AAC 0.00067 1
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.00035 1
mRNA rigosertib CTRPv2 pan-cancer AAC -0.00034 1
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.00032 1
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC -0.0003 1
mRNA prima-1 CTRPv2 pan-cancer AAC 0.00018 1
mRNA parbendazole CTRPv2 pan-cancer AAC -0.00015 1
mRNA BRD-K66453893 CTRPv2 pan-cancer AAC 0.00012 1
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC 0.0001 1
mRNA BRD1812 CTRPv2 pan-cancer AAC -0.00011 1
Download CSV